Harald S Haugen

US Patent:

20080159979, Jul 3, 2008

Filed:

Nov 7, 2006

Appl. No.:

11/557315

Inventors:

Emma E. Moore - Seattle WA, US
Harald S. Haugen - Seattle WA, US

International Classification:

A61K 38/20
A61K 39/395
A61P 17/06

US Classification:

424 852, 4241581

Abstract:

IL-17B is known to stimulate the proliferation of chondrocytes, bone, and is highly expressed in nervous tissue, resulting in repair of diseased tissue. When IL-17B is absent a marked negative effect on wound healing is noted. The present invention comprises providing IL-17B, by topical, parental, or other administration means, in order to accelerate the wound healing process. The present invention further encompasses a pharmaceutical composition and formulations thereof that utilize IL-17B, either alone or in combination with other cytokines or growth factors known to aid wound healing. The invention also contemplates methods of treating wounds in patients using this pharmaceutical composition.

US Patent:

20090285775, Nov 19, 2009

Filed:

Jun 15, 2009

Appl. No.:

12/484947

Inventors:

Emma E. Moore - Seattle WA, US
Harald S. Haugen - Seattle WA, US

International Classification:

A61K 38/20
A61P 17/02

US Classification:

424 852

Abstract:

IL-17B is known to stimulate the proliferation of chondrocytes, bone, and is highly expressed in nervous tissue, resulting in repair of diseased tissue. When IL-17B is absent a marked negative effect on wound healing is noted. The present invention comprises providing IL-17B, by topical, parental, or other administration means, in order to accelerate the wound healing process. The present invention further encompasses a pharmaceutical composition and formulations thereof that utilize IL-17B, either alone or in combination with other cytokines or growth factors known to aid wound healing. The invention also contemplates methods of treating wounds in patients using this pharmaceutical composition.

US Patent:

20070053872, Mar 8, 2007

Filed:

Aug 4, 2006

Appl. No.:

11/462603

Inventors:

Emma Moore - Seattle WA, US
Harald Haugen - Seattle WA, US

International Classification:

A61K 38/20

US Classification:

424085200, 424085100, 514012000, 424445000

Abstract:

IL-17B is known to stimulate the proliferation of chondrocytes, bone, and is highly expressed in nervous tissue, resulting in repair of diseased tissue. When IL-17B is absent a marked negative effect on wound healing is noted. The present invention comprises providing IL-17B, by topical, parental, or other administration means, in order to accelerate the wound healing process. The present invention further encompasses a pharmaceutical composition and formulations thereof that utilize IL-17B, either alone or in combination with other cytokines or growth factors known to aid wound healing. The invention also contemplates methods of treating wounds in patients using this pharmaceutical composition.